ABSTRACT Ca 2þ entry through L-type calcium channels (Ca V 1.2) is critical in shaping the cardiac action potential and initiating cardiac contraction. Modulation of Ca V 1.2 channel gating directly affects myocyte excitability and cardiac function. We have found that phospholemman (PLM), a member of the FXYD family and regulator of cardiac ion transport, coimmunoprecipitates with Ca V 1.2 channels from guinea pig myocytes, which suggests PLM is an endogenous modulator. Cotransfection of PLM in HEK293 cells slowed Ca V 1.2 current activation at voltages near the threshold for activation, slowed deactivation after long and strong depolarizing steps, enhanced the rate and magnitude of voltage-dependent inactivation (VDI), and slowed recovery from inactivation. However, Ca 2þ -dependent inactivation was not affected. Consistent with slower channel closing, PLM significantly increased Ca 2þ influx via Ca V 1.2 channels during the repolarization phase of a human cardiac action potential waveform. Our results support PLM as an endogenous regulator of Ca V 1.2 channel gating. The enhanced VDI induced by PLM may help protect the heart under conditions such as ischemia or tachycardia where the channels are depolarized for prolonged periods of time and could induce Ca 2þ overload. The time and voltage-dependent slowed deactivation could represent a gating shift that helps maintain Ca 2þ influx during the cardiac action potential waveform plateau phase.
INTRODUCTION
Voltage-gated calcium channels regulate important physiological processes such as excitation-contraction coupling, neurotransmitter release, hormone secretion, and gene expression (1) . The activity of L-type calcium channels (Ca V 1.2) is vital for the maintenance of normal excitability and Ca 2þ homeostasis in the heart. The dysregulation of Ca V 1.2 channels can lead to severe cardiac pathologies such as long QT syndrome (2) (3) (4) . The modulation of Ca V 1.2 channels by signaling pathways and associated proteins is important for many physiological and pathophysiological processes (5) (6) (7) . The gating of the a 1 subunit of the cardiac Ca V 1.2 channels is complex and tightly regulated (8) . Drugs that target the Ca V 1.2 a 1 subunit are used routinely to treat cardiovascular diseases such as hypertension and angina pectoris (9, 10) , and a 1 -associated proteins represent an important mechanism by which Ca V 1.2 channels are regulated (8, 11, 12) . Thus, drugs that target the pore-forming a 1 subunit or its associated regulatory proteins have high clinical relevance.
The FXYD family of ion transport regulators was first defined based on an invariant peptide sequence, known as the FXYD motif (13) . The FXYD motif is located on the N-termini of these single membrane spanning proteins and consists of five amino acids (Pro-Phe-X-Tyr-Asp). Seven members of the FXYD family (FXYD1-FXYD7) have been identified in mammals and are distributed widely in tissues that carry out fluid and solute transport (kidney, colon, breast/mammary gland, pancreas, prostate, liver, lung, and placenta), and in electrically excitable tissues (nervous system and muscle) (13, 14) .
FXYD1, also known as phospholemman (PLM), is localized to the sarcolemma and transverse tubules of cardiac myocytes where it regulates [Ca 2þ ] i through its interactions with Na,K-ATPase (NKA) (15) (16) (17) and the Na þ /Ca 2þ exchanger (NCX) (18) (19) (20) . As the primary pathway controlling Ca 2þ entry into the cardiac myocyte, the observed PLM-dependent changes in [Ca 2þ ] i merit the investigation of L-type calcium channels as a possible target for PLM modulation. We present what we believe to be the first report that currents through cardiac Ca V 1.2 channels are modulated by PLM. Our detailed kinetic analysis demonstrates that PLM slows the activation, slows deactivation in a time and voltage dependent manner, and enhances voltage-dependent inactivation. Slowed deactivation is predicted to enhance the relative Ca 2þ entry during the repolarization phase of the cardiac action potential. These dynamic PLM-dependent changes in Ca V 1.2 channel gating are expected to directly alter cell excitability, Ca 2þ homeostasis and cardiac function. (16) . Coimmunoprecipitation experiments carried out on HEK293 cell lysates were carried out as described previously (21) .
MATERIALS AND METHODS

Coimmunoprecipitations and Western blot analysis
Whole-cell patch-clamp electrophysiology
Whole-cell patch-clamp experiments were carried out as described previously (22 
RESULTS
Association of PLM with native and exogenously expressed Ca V 1.2 channels
Recent work showing that PLM plays an important role in regulating excitability and Ca 2þ homeostasis in myocardium (15) (16) (17) (18) (19) 26) prompted us to investigate the potential role PLM may play in regulating cardiac Ca V 1.2 channels. We carried out coimmunoprecipitation (co-IP) experiments to test for the potential association of PLM with Ca V 1.2 channels using solubilized membranes from guinea pig cardiac myocytes and lysates of transfected HEK293 cells (Fig. 1) . As expected, Ca V 1.2 and PLM were observed when the solubilized membranes were subjected to Western blot analysis ( Fig. 1 A, lane 1) . Immunoprecipitation (IP) experiments using the anti-Ca V 1.2 antibodies coprecipitated PLM demonstrating an association between these proteins ( Fig. 1 A, lane 4) . Both Ca V 1.2 and PLM were absent in the insoluble and post-IP fractions ( Fig. 1 A, lanes 2 and  3) and neither protein was detected in the IgG control lane (Fig. 1 A, lane 5) . The plasma membrane Ca 2þ -ATPase (PMCA) has been shown previously to have no interaction with PLM (16), was used here as a negative control (Fig. 1 B) . As shown previously (15, 16, 19) , we found that PLM was able to co-IP with NCX1 ( Fig. 1 C) or NKA a 1 subunit (not shown). These results indicate that the association between Ca V 1.2 and PLM is specific.
We were interested determining whether PLM was capable of associating with other members of the Ca V superfamily. Therefore, we carried out co-IP experiments using HEK293 cells transiently expressing either Flag-tagged Ca V 1.2 ( Fig. 1 D) , or Ca V 2.1 ( Fig. 1 E) channels plus PLM. Consistent with our findings using guinea pig membranes, we found that co-IP was obtained for PLM with an anti-Flag Ab only in cells expressing both Flag-tagged Ca V 1.2 channels and PLM (Fig. 1D) , whereas no PLM co-IP was observed when using the Ca V 2.1 Ab (Fig. 1 E) . The reverse experiment of using the PLM Ab showed a co-IP of Ca V 1.2, but not Ca V 2.1 (not shown). Thus, PLM seems to specifically interact with Ca V 1.2 channels.
PLM specifically alters Ca V 1.2 channel gating
The association between PLM and Ca V 1.2 channels suggests the potential for gating modulation, which was examined using the HEK293 cell heterologous expression system. Whole-cell recordings from HEK293 cells expressing Ca V 1.2 (Fig. 2 , A-C) or Ca V 2.1 (Fig. 2, D-F ) channels in the absence (empty vector) and presence of PLM were conducted. We found that PLM slows Ca V 1.2 channel activation and left-shifts the activation versus voltage relationship (Fig. 2, A and C) . These currents were generated by 25 ms depolarizing pulses to minimize the effect of voltage-dependent inactivation in our experiments (see below), and Ba 2þ was used as the charge carrier to eliminate Ca 2þ -dependent inactivation (12, (27) (28) (29) . The sample traces in Fig. 2 A show normalized currents (at À10 mV) from different cells (5 PLM) to highlight the effect of PLM to slow activation. The activation versus voltage relationship measured from tail currents was left-shifted >20 mV so that the half activation voltage (V h ) changed from 25.0 to 4.1 mV with PLM and the relationship exhibited a much steeper slope factor (e-fold/ 23.3 vs. 12.9 mV) (Fig. 2 C) . Consequently, at þ10 mV, <40% of the channels were activated in the absence of PLM, whereas nearly 70% of the channels are activated in the presence of PLM. In contrast to Ca V 1.2, PLM failed to alter the activation kinetics (Fig. 2 D) or the voltage-dependence of activation of neuronal Ca V 2.1 ( Fig. 2 , E and F) or Ca V 2.2 (not shown) channels. Thus, PLM selectively associates with and modulates Ca V 1.2 but not Ca V 2.1 and Ca V 2.2 channels.
The voltage-dependence of PLM-induced slowed Ca V 1.2 channel activation was determined using currents generated during the I/V protocol (Fig. 3) . The speed of activation was quantified by measuring the time required for the current Biophysical Journal 98(7) 1149-1159 to increase from 10 to 90% of the peak current (T 10À-90 ). Activation was significantly slowed at hyperpolarized voltages close to the threshold for channel activation, but no significant effect was observed at voltages R0 mV (Fig. 3 B) . It is possible that the effect of PLM on activation kinetics is voltage dependent. However, inactivation has been shown to impact the measurement of activation kinetics (30) , so this interpretation is confounded by our observation that PLM expression also enhances voltage dependent inactivation at more depolarized voltages (see below).
PLM slows deactivation of Ca V 1.2 channels
Activation and deactivation share the same gating machinery operating in opposite directions. Thus, the PLM effect on activation may also be reflected in altered deactivation kinetics. Fig. 4 A shows superimposed tail currents from Ca V 1.2 channels 5 PLM to highlight the effect of PLM on deactivation. Tail current deactivation was fit using a single exponential equation to determine the deactivation t (t Deact ). Using the I/V protocol ( Fig. 2) , t Deact was determined following a range of depolarizing voltages and showed an increase with voltage that was enhanced by PLM (Fig. 4 B) . t Deact was significantly larger at all voltages for (þ)PLM compared with (À)PLM. These findings suggest that the interaction of PLM with Ca V 1.2 channels slows channel closing.
It is well established that deactivation is slowed when Ca V 1.2 channels switch from mode 1 (low P o ) into mode 2 (high P o ) gating (31, 32) and this gating switch is both Biophysical Journal 98 (7) 1149-1159 time-and voltage-dependent (32) . Thus, if PLM enhances mode switching, the effect should depend on both step duration and voltage. We tested this prediction by measuring the time course (0-250 ms step duration) for slowed deactivation at À10; Fig. 4 C) , þ30 (Fig. 4 D) , and þ80 mV (Fig. 4 E) . As expected, Ca V 1.2 currents in the absence of PLM exhibited a moderate (þ80 mV) time-and voltage-dependent slowing of deactivation (increased t Deact ), suggesting that some channels are transitioning from mode 1 to mode 2 gating (Fig. 4, C-E) . In the presence of PLM, t Deact was significantly larger than (À)PLM at þ80 mV for pulse durations R80 ms, and for þ30 mV at 250 ms. It is noteworthy that changes in t Deact were not correlated with current amplitude, indicating that the PLM-induced changes do not result from voltage-clamp errors. Thus, PLM directly alters Ca V 1.2 gating by enhancing the voltage-and time-dependent slowing of deactivation, consistent with PLM promoting mode 2 gating. Additional single channel experiments are required to confirm this intriguing hypothesis.
PLM specifically enhances voltage-dependent inactivation of Ca V 1.2 channels
Examination of the records in Fig. 3 A shows an apparent enhancement of voltage-dependent inactivation (VDI) at the most depolarized voltage (20 mV) by PLM. This was further investigated using longer voltage steps of 300 (Fig. 5 A) and 1000 ms (Fig. 5 C) where VDI is larger and more easily measured. Ca V 1.2 channels exhibit little inactivation at the end of a 300 ms step in the absence of PLM, but inactivation is significantly increased in the presence of PLM. This was quantified by measuring the fraction of current remaining at the end of 300 ms (R 300 ), which was decreased significantly by PLM at voltages Rþ10 mV (Fig. 5 B) . Longer voltage steps (1000 ms) were used to assess the impact of PLM on the speed of inactivation. Currents recorded in the presence of PLM inactivated faster (i.e., decreased inactivation t) (Fig. 5 E) and the fraction of inactivating current was increased (Fig. 5, C and D) , suggesting that PLM may enhance the transition rate from O / I (see below). Ca 2þ influx via Ca V 1.2 channels induces Ca 2þ -dependent inactivation (CDI), but we found that PLM does not alter CDI (Fig. S1 in the Supporting Material). Therefore, it seems PLM specifically enhances the speed of VDI.
In addition to a dynamic role in shaping the cardiac action potential, inactivation is critical for establishing the number of available channels for activation and, as a result, the amount of Ca 2þ entering the cell during each cardiac cycle (9,10). We used a standard 3-pulse protocol to determine the voltage-dependence of channel availability in the absence and presence of PLM. Peak currents were measured at 0 mV before and after 30-s steps to voltages ranging from À110 to 0 mV. The postpulse/prepulse ratio (I/I max ) plotted against voltage (i.e., the h 30 curve) is depicted in Fig. 5 F. PLM steepens the voltage-dependence (Boltzmann slope factor) and induces a~10 mV depolarizing shift in the h 30 curve. Similar experiments carried out on cells expressing neuronal Ca V 2.1 channels in the absence and presence of PLM exhibited no change in either the half inactivation voltage or the slope factor (not shown). Thus, PLM seems to have the capacity to selectively increase the number of available Ca V 1.2 channels at depolarized resting membrane potentials.
PLM promotes a deep inactivated state from which recovery is slow
To better understand how PLM affects inactivation of Ca V 1.2 channels, we investigated the recovery from inactivation in the absence and presence of PLM. Inactivation was induced by 500 ms steps to þ10 mV and quantified as the ratio of peak postpulse to prepulse currents evoked by steps to 0 mV (Fig. 6 A) . The recovery from inactivation time course was fit by a single exponential function to determine the recovery t (Fig. 6 B) . Ca V 1.2 channels inactivated by 58% in (À)PLM and 64% in (þ)PLM over the 500 ms step, and the recovery t was nearly identical for Ca V 1.2 channels 5 PLM (Fig. 6 B) . However, the magnitude of recovery was significantly reduced in the presence of PLM, suggesting that PLM places the Ca V 1.2 channels into a deeper inactivated state from which recovery is slow. This hypothesis was tested using longer (20 s) voltage steps to place more channels into the deeper inactivated state (Fig. 6 C) . The fraction of inactivating current resulting from 20 s depolarizing steps to þ10 mV was significantly larger in the presence of PLM (98%) than was observed in the absence of PLM (87%) (Fig. 6 D) . Interestingly, 36% of the inactivated Ca V 1.2 channels (À)PLM had recovered from inactivation by the first measurement point (30 ms), whereas only 12% of the channels (þ)PLM had recovered by this time. This fast recovery is consistent with the recovery t (~20 ms) measured after the 500 ms inactivating steps (Fig. 6 B) , and further supports our hypothesis that PLM enhances the transition of channels into a deep inactivated state. Ca V 1.2 channels 5 PLM recovered substantially more slowly after the 20-s step compared to the 500-ms step (10 s vs. 20 ms), but the recovery rates from the deep inactivated state were indistinguishable in the absence and presence of PLM (Fig. 6 D) . Therefore, PLM increases the fraction of channels that enter the deep FIGURE 3 PLM slows activation of Ca V 1.2 channels. (A) Ba 2þ currents 5 PLM were generated by 150 ms voltage steps to À20, 0, and þ20 mV from a holding potential of À100 mV. Slowing of activation is pronounced at À20 and 0 mV and modest at þ20 mV in the presence of PLM. (B) The time required for channels to activate from 10 to 90% of the maximum is plotted versus step voltage 5 PLM. t 10-90 is significantly increased in the presence of PLM at À20 and À10 mV (p < 0.05, n ¼ 9-12).
Biophysical Journal 98(7) 1149-1159 inactivated state, but does not alter the rate at which the channels exit from that state.
PLM promotes dynamic changes in Ca 2þ entry
PLM-induced slowing of activation and enhancement of inactivation are expected to combine to reduce Ca 2þ entry, yet the slowing of deactivation is expected to increase Ca 2þ entry during the cardiac action potential (4). Because PLM-induced changes in activation, inactivation, and deactivation all appear to be voltage-and time-dependent, it is likely that PLM temporally changes Ca 2þ entry during membrane depolarization and repolarization. The effect of PLM-induced gating changes on Ca 2þ flux can be demonstrated by comparing difference currents (Fig. 7, A-E) recorded in external solution with 10 mM Ca 2þ as charge carrier. The integral of difference current provides a quantitative measure of the changes in the number of Ca 2þ ions permeating the channels 5 PLM at various time points during the depolarizing step (Fig. 7 F) . The integral is negative at potentials <10 mV, indicating that Ca 2þ influx is reduced during the depolarizing step in the presence of PLM, which results from slowed activation. The difference current integral becomes positive at potentials >10 mV because slowed deactivation greatly increases Ca 2þ influx after the membrane is repolarized.
PLM increases Ca V 1.2 currents during the repolarization phase of the cardiac action potential
It is important to note that the changes in ionic flux elucidated by the difference currents (Fig. 7) clearly highlight important temporal aspects of PLM-induced changes in Ca V 1.2 channel gating. For example, slowed activation seems to play a dominant role at reducing influx during early depolarization, but slowed deactivation greatly increases flux upon repolarization. Given the time and voltage-dependent slowing of deactivation, we postulated that PLM would increase calcium entry during the repolarization phase of the cardiac action potential (cAP) after the~200 ms plateau phase. To test this, we recorded Ca V 1.2 currents 5 PLM generated by a human cAP waveform in 5 mM Ca 2þ (4, 33) . The cAP-generated currents 5 PLM exhibited a stable plateau phase and monotonic decline during repolarization. The effect of PLM on Ca 2þ flux during the repolarization phase was assessed by normalizing currents 5 PLM during the plateau phase, which showed that the duration of cAP induced-currents is increased when Ca V 1.2 channels are expressed with PLM (Fig. 8 A) . This enhancement was verified by integrating the normalized current over the last 200 ms of the cAP (225-425 ms), which showed a significant increase (þ)PLM. Thus, the interaction of PLM with Ca V 1.2 channels significantly increases Ca 2þ influx during the repolarization phase of the cAP, which suggests that PLM plays a role in setting cAP duration and the QT interval.
DISCUSSION
We believe our findings are the first to show that PLM associates with and modulates the gating kinetics of Ca V 1.2 (L-type), but not Ca V 2.1 (P/Q-type) or Ca V 2.2 (N-type; not shown) channels. PLM was found to alter four important gating processes of Ca V 1.2 channels: 1), activation kinetics were slowed at voltages near the threshold for channel FIGURE 4 PLM slows deactivation of Ca V 1.2 channels. (A) Sample tail currents recorded in Ba 2þ at À50 mV are shown after a 100 ms step to þ10 mV. (B) Rate of deactivation 5 PLM was evaluated using single exponential fits of tail currents recorded following voltage steps from À20 to þ80 mV. Values of t versus voltage plots indicate that PLM slows deactivation at all voltages tested (asterisk) (n ¼ 5). (C-E) The development of slowed deactivation was evaluated using standard envelope protocol in the absence and presence of PLM. Cells were stepped to (C) À10, (D) þ30, and (E) þ80 mV with various durations (0-250 ms) followed by repolarizing steps to À50 mV. Tails currents were assessed using single exponential fits as described in B to determine voltage and time dependent values for t. Significant differences between (À) and (þ) PLM are indicated by an asterisk (n ¼ 4-5).
Biophysical Journal 98(7) 1149-1159 activation; 2), deactivation kinetics were slowed following voltage steps comparable in magnitude and duration to that of the human cardiac action potential (cAP); 3), VDI was enhanced at potentials corresponding to the plateau phase of the cAP; and 4), an increased number of channels enter a deep inactivated state from which recovery is slow. Below, we discuss these PLM-induced changes in Ca V 1.2 gating in greater detail and how these PLM-dependent changes are likely to affect the cardiac action potential and contractility.
PLM-induced changes in inactivation
Recent publications have presented evidence highlighting the importance of calcium channel inactivation to cardiac function (2-4,34-39), which motivated our investigation of a potential PLM-dependent modulation of VDI. Over step depolarizations similar to the plateau phase of the cAP, PLM accelerates the rate of and increases the magnitude of VDI. The accelerated VDI at depolarized voltages (i.e., þ20 mV) suggests the PLM increases the rate constant governing transition from the open (O) to inactivated (I) state, whereas the increase in VDI magnitude suggests that PLM does little to the I / O rate. This latter point is substantiated by the observation that PLM enhances the fraction of inactivating channels, which seems to be correlated with increased occupancy of a deep inactivation state from which recovery is slow (t > 10 s). We also found that the co-expression of PLM affects steady-state inactivation by shifting the half inactivation voltage~10 mV depolarized and increasing voltage-dependence inactivation (smaller Boltzmann slope factor). The combination of right-shifted V h and steeper voltage dependence by PLM increases the number of available channels at voltages near resting membrane potential (À80 to À50 mV). Thus, the association of PLM with Ca V 1.2 channels may play an important role in regulating the number of available channels under physiological and pathological conditions.
PLM-induced slowing of activation and deactivation
We observed a PLM-induced slowing of activation, but this slowing is strongly voltage-dependent and most easily . PLM speeds the rate of inactivation (A and C) and increases the fraction of inactivating channels at 300 and 1000 ms. (B and D) The R 300 and R 1000 values were determined by measuring the fraction of current remaining at the end of (B) 300 ms (R 300 ) or (D) 1000 ms (R 1000 ) voltage steps. Significantly different values between (À)PLM and (þ)PLM are indicated by an asterisk (p < 0.05). R 300 values are averaged from 13 cells whereas 12-14 cells were used for the R 1000 values. (E) Single exponential fits through currents evoked by 1000 ms voltage steps to either þ10 or þ20 mV indicates that PLM significantly speeds the kinetics for inactivation (t) at þ20 mV (p < 0.05). (F) A standard three-pulse protocol consisting of two 150-ms test pulses to 0 mV (pre-and postpulse) bracketing 30-s steps to voltages ranging from À110 to 0 mV was used to assess the effect PLM has on steady-state inactivation. The interval between each sweep was 80 s to allow channels to recover from previous inactivation. The postpulse/ prepulse ratio (I/I max ) is plotted versus inactivating voltage. Single Boltzmann fits were used to determine values for V half and the slope factor. In the presence of PLM, the steady-state inactivation curve is right-shifted 7.7 mV (p < 0.05, n ¼ 4-6), and the slope factor is decreased from 13.5 5 2.3 to 9.2 5 2.1 (p < 0.05, n ¼ 4-6).
Biophysical Journal 98(7) 1149-1159 observed at potentials <0 mV. The voltage-dependence of slowed activation may result from the concurrent PLMinduced enhancement of inactivation that is more prevalent at depolarized voltages. However, during preliminary mutagenesis experiments we have identified PLM mutants that fail to enhance VDI, but still selectively slow activation at voltages <0 mV (K. Guo, X. Wang, G. Gao, C. Huang, K. S. Elmslie, B. Z. Peterson, unpublished data). This supports the idea that the PLM effect on activation is strongly voltage-dependent. Given that the C / O transition is voltage independent (4,36), the mutation findings suggest that the effect of PLM is to decrease the voltage-dependent C / C transitions, which predicts that Ca V 1.2 channel On-gating currents will be slowed by PLM. Those experiments are ongoing currently.
Ca V 1.2 channels have been shown to exhibit modal gating behavior (31, 40) , where the channels exist in one of three gating modes: mode 1 gating is characterized by short FIGURE 6 PLM promotes a deep inactivated state from which recovery is slow. (A) Recovery from a short inactivating pulse. Ba 2þ currents were evoked using a threepulse protocol with 100 ms pre-and postpulses to 0 mV bracketing a 500-ms inactivating pulse to þ10 mV. The interval between the inactivation pulse and postpulse (recovery time) was increased to determine the recovery time for inactivation. The interval between sweeps was 30 s. Ca V 1.2 currents (5)PLM were scaled to peak prepulse current and superimposed for easier comparison. Biophysical Journal 98 (7) Role of PLM in regulating excitability and contractility
The precise physiological role of PLM is not yet resolved partly because the relationships between PLM and NKA (6, 15, (44) (45) (46) (47) , NCX (7, 48, 49) and, as we report here, Ca V 1.2 channels, are complex, and partly because there exists some variability in the literature regarding the effect PLM expression has on contractility (7, 44, 45, 48, 50) . Results from isolated myocytes suggest PLM induces a decrease in contractile strength in low Ca 2þ and has no effect on contractility in physiological Ca 2þ (7, 48, 50) . However, results from whole heart suggest that PLM increases contractility in physiological Ca 2þ (45) . Our finding that PLM modulates the gating of cardiac Ca V 1.2 channels further increases the complexity of the relationship between PLM expression and contractility. Changes in calcium channel gating, such as impaired VDI and slowed deactivation, profoundly affect cardiac function (2-4,34-38,51). PLM-dependent slowed deactivation seems to increase Ca 2þ entry during the repolarization phase of the cAP and may account for the observed decrease in left ventricular pressure measured from PLM knockout mice (45) . In addition, by increasing the fraction of channels occupying the deep inactivated state, PLM may help protect the heart under conditions such as ischemia or tachycardia where the channels undergo prolonged depolarization and the myocytes are vulnerable to Ca 2þ overload.
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A figure is available at http://www.biophysj.org/biophysj/supplemental/ S0006-3495(09)01799-8. Biophysical Journal 98(7) 1149-1159
